Capsule Summary Slidesets

Share

Program Content

Activities

  • GIM 4 LEAD: Extended Adjuvant Letrozole
    GIM4 LEAD: Phase III Trial of Extended Adjuvant Therapy With Letrozole After Sequential Endocrine Therapy in Patients With HR+ Early Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2019

    Expires: June 03, 2020

  • SOPHIA: Margetuximab + CT for MBC
    SOPHIA: Phase III Trial of Margetuximab + CT vs Trastuzumab + CT in Patients With HER2+ Metastatic Breast Cancer After Standard Anti-HER2 Therapies
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2019

    Expires: June 04, 2020

  • NALA: Neratinib in HER2+ MBC
    Phase III NALA: Neratinib + Capecitabine vs Lapatinib + Capecitabine in HER2+ MBC Previously Treated With HER2-Targeted Therapies
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2019

    Expires: June 05, 2020

  • Atezolizumab + nab-pac for TNBC
    Atezolizumab + nab-Paclitaxel in Previously Untreated Advanced Metastatic TNBC: Updated OS Analysis of Phase III IMpassion130
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2019

    Expires: June 04, 2020

  • Young-PEARL
    Young-PEARL Phase II Study of Palbociclib, Exemestane, and Leuprolide vs Capecitabine in Premenopausal Women With HR+/HER2- MBC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2019

    Expires: June 05, 2020

  • MONALEESA-7: OS
    Phase III MONALEESA-7: OS Analysis of Ribociclib + ET vs Placebo + ET in Pre/Perimenopausal Women With HR+/HER2- Advanced Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 11, 2019

    Expires: June 09, 2020

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Astellas Seattle Genetics

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Novartis Pharmaceuticals Corporation

Puma Biotechnology, Inc.

Taiho Oncology Inc

Tesaro